The multiphysics of prion-like diseases: progression and atrophy

Abstract

Many neurodegenerative diseases are related to the propagation and accumulation of toxic proteins throughout the brain. The lesions created by aggregates of these toxic proteins further lead to cell death and accelerated tissue atrophy. A striking feature of some of these diseases is their characteristic pattern and evolution, leading to well-codified disease stages visible to neuropathology and associated with various cognitive deficits and pathologies. Here, we simulate the anisotropic propagation and accumulation of toxic proteins in full brain geometry. We show that the same model with different initial seeding zones reproduces the characteristic evolution of different prion-like diseases. We also recover the expected evolution of the total toxic protein load. Finally, we couple our transport model to a mechanical atrophy model to obtain the typical degeneration patterns found in neurodegenerative diseases.

arXiv comment5 pages/5 figures

References in corpus (2)

• Alzheimer's disease: a mathematical model for onset and progression
• A simplified exactly solvable model for beta-amyloid aggregation

Cited by in corpus (10)

• Neuronal Oscillations on Evolving Networks: Dynamics, Damage, Degradation, Decline, Dementia, and Death
• Anisotropic Diffusion and Traveling Waves of Toxic Proteins in Neurodegenerative Diseases
• Exploring tau protein and amyloid-beta propagation: a sensitivity analysis of mathematical models based on biological data
• Discontinuous Galerkin approximations of the heterodimer model for protein-protein interaction
• Mechanism, scaling and rates of protein aggregation from in vivo measurements
• Calibration of Biophysical Models for tau-Protein Spreading in Alzheimer's Disease from PET-MRI
• A coupled mathematical and numerical model for protein spreading and tissue atrophy, applied to Alzheimer's disease
• Reinforcement Learning based Disease Progression Model for Alzheimer's Disease
• A whole-brain model of amyloid beta accumulation and cerebral hypoperfusion in Alzheimer's disease
• A Network-Guided Reaction-Diffusion Model of AT[N] Biomarkers in Alzheimer's Disease